You have 9 free searches left this month | for more free features.

Lymphoproliferative Disorders

Showing 1 - 25 of 9,967

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Recurrent Lymphoproliferative Disorder, Refractory Lymphoproliferative Disorder Trial in Duarte (Leflunomide)

Active, not recruiting
  • Recurrent Lymphoproliferative Disorder
  • Refractory Lymphoproliferative Disorder
  • Duarte, California
    City of Hope Medical Center
Jun 7, 2022

Epstein-Barr Virus Infections, Lymphoma, Lymphoproliferative Disorder Trial run by the NCI (Nivolumab)

Recruiting
  • Epstein-Barr Virus Infections
  • +3 more
  • Nivolumab
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 6, 2022

Myeloproliferative Disorders, Lymphoproliferative Disorders Trial in Pierre-Bénite (Blood collection for the evaluation of the

Not yet recruiting
  • Myeloproliferative Disorders
  • Lymphoproliferative Disorders
  • Blood collection for the evaluation of the anti-drugs sensitivity
  • Pierre-Bénite, France
  • +1 more
Mar 2, 2022

Expression of CD19 Complex in Lymphoproliferative Disorders

Not yet recruiting
  • Lymphoproliferative Disorders
  • Flow cytometry
  • (no location specified)
Feb 2, 2021

Childhood Acute Lymphoblastic Leukemia/Lymphoma

Recruiting
  • Childhood Leukemia and Lymphoma
    • Petah Tikva, Israel
    • +1 more
    Sep 30, 2021

    Pathogenesis of Hematologic Malignancies

    Enrolling by invitation
    • Acute Leukemia
    • +3 more
    • blood draw, bone marrow procedure, or tissue biopsy
    • Portland, Oregon
      OHSU Knight Cancer Institute
    Feb 17, 2022

    Family Study of Lymphoproliferative Disorders

    Recruiting
    • Lymphoma, Non-Hodgkin
    • +4 more
      • Rochester, Minnesota
        Mayo Clinic
      Aug 30, 2021

      Ascertainment of Families for Genetic Studies of Familial

      Recruiting
      • Lymphoma
      • +4 more
        • Basking Ridge, New Jersey
        • +5 more
        Oct 7, 2021

        Lymphoproliferative Disorders, Autoimmune Lymphoproliferative, Primary T-cell Immunodeficiency Disorders Trial in Bethesda,

        Recruiting
        • Lymphoproliferative Disorders
        • +4 more
        • Immunosuppression Only Conditioning
        • +3 more
        • Bethesda, Maryland
        • +1 more
        Aug 24, 2022

        Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Chronic Lymphocytic Leukemia Trial in Ann Arbor (Pacritinib)

        Terminated
        • Lymphoma, T-Cell, Cutaneous
        • +6 more
        • Ann Arbor, Michigan
          University of Michigan Rogel Cancer Center
        Jan 20, 2021

        Post-transplant Lymphoproliferative Disorder Trial in Cleveland (Rituximab, Acalabrutinib, CT scans)

        Recruiting
        • Post-transplant Lymphoproliferative Disorder
        • Cleveland, Ohio
          Cleveland Clinic, Case Comprehensive Cancer Center
        Feb 2, 2022

        Primary T-cell Immunodeficiency Disorders, Common Variable Immunodeficiency, Immune System Diseases Trial in Bethesda,

        Recruiting
        • Primary T-cell Immunodeficiency Disorders
        • +4 more
        • Immunosuppression Only Conditioning -Closed with amendment L
        • +4 more
        • Bethesda, Maryland
        • +1 more
        Jul 26, 2022

        Post-transplant Lymphoproliferative Disease, Transplant-Related Hematologic Malignancy Trial in London (Autologous EBV-CTL

        Active, not recruiting
        • Post-transplant Lymphoproliferative Disease
        • Transplant-Related Hematologic Malignancy
        • Autologous EBV-CTL transduced with vector SFG-CNA12
        • +2 more
        • London, United Kingdom
        • +1 more
        Jan 19, 2022

        Follicular Lymphoma, Indolent B-Cell Non-Hodgkin Lymphoma, Marginal Zone Lymphoma Trial in Seattle (Laboratory Biomarker

        Recruiting
        • Follicular Lymphoma
        • +2 more
        • Laboratory Biomarker Analysis
        • Pembrolizumab
        • Seattle, Washington
          Fred Hutch/University of Washington Cancer Consortium
        Apr 11, 2022

        Epstein-Barr Virus Infections Trial in Strasbourg (Rituximab, control group)

        Recruiting
        • Epstein-Barr Virus Infections
        • Strasbourg, France
          Les Hôpitaux Universitaires de Strasbourg
        Dec 7, 2021

        Lymphoma, Mantle-Cell, Lymphoma, Lymphoproliferative Disorders Trial (Zilovertamab, Ibrutinib, Placebo)

        Not yet recruiting
        • Lymphoma, Mantle-Cell
        • +7 more
        • (no location specified)
        Jun 21, 2022

        Epstein-Barr Virus (EBV) Infections, Lymphoproliferative Disorders, EBV+ Associated Lymphoma Trial (tabelecleucel)

        Available
        • Epstein-Barr Virus (EBV) Infections
        • +11 more
        • tabelecleucel
        • (no location specified)
        Feb 15, 2022

        Lymphoma, Lymphoma, Mantle-Cell, Tumors by Histologic Type Trial (IM19 CAR-T cells, Cyclophosphamide, Fludarabine)

        Not yet recruiting
        • Lymphoma
        • +4 more
        • IM19 CAR-T cells
        • +2 more
        • (no location specified)
        Nov 30, 2021

        Epstein-Barr Virus Infections, Post-Transplant Lymphoproliferative Disorder, Lymphoma Trial in Montreal (Group A, Group B)

        Recruiting
        • Epstein-Barr Virus Infections
        • +2 more
        • Group A
        • Group B
        • Montreal, Quebec, Canada
          Hôpital Maisonneuve-Rosemont
        Apr 5, 2022

        EBV-Related Hodgkin Lymphoma, Lymphoproliferative Disorders, EBV Related Non-Hodgkin's Lymphoma Trial in Houston (Dose Level 1A:

        Not yet recruiting
        • EBV-Related Hodgkin Lymphoma
        • +2 more
        • Dose Level 1A: 2 x 10^7 cells/m2
        • +4 more
        • Houston, Texas
        • +1 more
        Feb 7, 2022

        Lymphoma, Multiple Myeloma, Leukemia Trial in Fuzhou (68Ga-Pentixafor)

        Recruiting
        • Lymphoma
        • +2 more
        • Fuzhou, Fujian, China
          Department of Nuclear Medicine, First Affiliated Hospital of Fuj
        Apr 6, 2021

        Lymphoma, Lymphoma, Non-Hodgkin, Immune System Diseases Trial in Chapel Hill (ATLCAR.CD30 cells)

        Recruiting
        • Lymphoma
        • +7 more
        • ATLCAR.CD30 cells
        • Chapel Hill, North Carolina
          Lineberger Comprehensive Cancer Center at University of North Ca
        Dec 2, 2021

        Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin Trial in Chapel Hill, Winston-Salem (ATLCAR.CD30 cells)

        Active, not recruiting
        • Hodgkin Disease
        • +8 more
        • ATLCAR.CD30 cells
        • Chapel Hill, North Carolina
        • +1 more
        Mar 2, 2022

        Waldenström Macroglobulinemia Trial in Vandoeuvre les Nancy (Blood or bone marrow samples)

        Completed
        • Waldenström Macroglobulinemia
        • Blood or bone marrow samples
        • Vandoeuvre les Nancy, France
          CHRU Nancy
        Aug 1, 2021

        Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Detroit (3'-deoxy-3'-[18F]fluorothymidine)

        Recruiting
        • Brain and Central Nervous System Tumors
        • +8 more
        • 3'-deoxy-3'-[18F]fluorothymidine
        • Detroit, Michigan
          Barbara Ann Karmanos Cancer Institute
        Mar 30, 2022